Autotransporters are the largest family of surface bound and secreted proteins in Gram-negative bacteria, present in World Health Organization (WHO) listed critical high priority pathogens such as Escherichia coli, Serratia and Neisseria ssp. Autotransporter proteins facilitate multiple functions in bacterial infection, such as aggregation and biofilm formation, host colonisation and invasion, along with tissue destruction and immunomodulation [1]. We are interested in understanding the molecular mechanisms underlaying how autotransporters contribute to bacterial pathogenesis. Using precision structural and molecular approaches we have shown that autotransporter adhesins like Ag43 adopt a β-helical structure and that head-to-tail interactions between Ag43 molecules in adjacent E. coli cells lead to bacterial clumping [2-4]. We have further demonstrated that this is a universally conserved mechanism for biofilm formation among autotransporter adhesins. Our research also investigates secreted autotransporter toxins. We have recently revealed that the Ssp toxin from Serratia marcescens, displays the common structural architecture for autotransporter toxins consisting of a protease "war head" attached to a β-helix stalk. However, the protease structural layout is unique amongst the many bacterial toxins that have been structurally characterised, and these idiosyncrasies are required for its cytotoxicity [5]. We are using the new fundamental knowledge on the autotransporter proteome to develop inhibitory molecules that disarm rather than kill bacteria, such as our recently patented E. coli biofilm blocker [6].